{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:13:43Z","timestamp":1784780023184,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.antiviral.2014.11.009","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T21:38:56Z","timestamp":1417037936000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["T cell responses in hepatitis C virus infection: Historical overview and goals for future research"],"prefix":"10.1016","volume":"114","author":[{"given":"Lauren","family":"Holz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rehermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.11.009_b0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2014.07.005","article-title":"Signatures of protective memory immune responses during HCV reinfection","volume":"147","author":"Abdel-Hakeem","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.11.009_b0015","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0030","doi-asserted-by":"crossref","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.11.009_b0035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal models for the study of hepatitis C virus infection and related liver disease","volume":"142","author":"Bukh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0040","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1128\/JVI.00142-08","article-title":"Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain","volume":"82","author":"Bukh","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0045","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.02654-10","article-title":"Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8(+) T cells in early viral evolution","volume":"85","author":"Callendret","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI117694","article-title":"Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif","volume":"95","author":"Cerny","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.11.009_b0055","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus","volume":"100","author":"Chang","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.11.009_b0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.11.009_b0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2014.11.009_b0070","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20050121","article-title":"Cellular immune selection with hepatitis C virus persistence in humans","volume":"201","author":"Cox","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/cimm.2000.1683","article-title":"Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection","volume":"203","author":"Cucchiarini","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0080","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1128\/JVI.76.24.12584-12595.2002","article-title":"Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection","volume":"76","author":"Day","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0085","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI200318509","article-title":"Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers","volume":"112","author":"Day","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.11.009_b0090","first-page":"376","article-title":"Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response","volume":"119","author":"Dazert","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.11.009_b0095","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.11.009_b0100","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1128\/JVI.71.8.6011-6019.1997","article-title":"Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection","volume":"71","author":"Diepolder","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.11.009_b0115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1074-7613(01)00245-X","article-title":"The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes","volume":"15","author":"Erickson","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2014.11.009_b0125","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1143767","article-title":"A whole-genome association study of major determinants for host control of HIV-1","volume":"317","author":"Fellay","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.11.009_b0130","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1128\/JVI.78.18.9782-9789.2004","article-title":"Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity","volume":"78","author":"Fernandez","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/hep.23319","article-title":"Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection","volume":"51","author":"Fuller","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0145","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1073\/pnas.1312772110","article-title":"Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)","volume":"110","author":"Fuller","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2014.11.009_b0150","doi-asserted-by":"crossref","first-page":"e63818","DOI":"10.1371\/journal.pone.0063818","article-title":"A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection","volume":"8","author":"Gardiner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.11.009_b0155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.11.009_b0160","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","article-title":"Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C","volume":"117","author":"Gerlach","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0165","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.21365","article-title":"Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence","volume":"44","author":"Golden-Mason","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0170","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1128\/JVI.00639-09","article-title":"Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells","volume":"83","author":"Golden-Mason","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.11.009_b0180","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1128\/JVI.75.12.5550-5558.2001","article-title":"Sustained dysfunction of antiviral CD8(+) T lymphocytes after infection with hepatitis C virus","volume":"75","author":"Gruener","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0185","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1073\/pnas.96.10.5692","article-title":"Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers","volume":"96","author":"He","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2014.11.009_b0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2014.05.012","article-title":"Pushing to a cure by harnessing innate immunity against hepatitis C virus","volume":"108C","author":"Ireton","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.11.009_b0195","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2008.12.034","article-title":"Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model","volume":"136","author":"Jo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0200","doi-asserted-by":"crossref","first-page":"e1003422","DOI":"10.1371\/journal.ppat.1003422","article-title":"Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C","volume":"9","author":"Kared","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.11.009_b0205","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/JVI.01499-09","article-title":"Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution","volume":"84","author":"Kasprowicz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0215","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2010.09.042","article-title":"Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes","volume":"140","author":"Kim","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0220","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA","volume":"277","author":"Kolykhalov","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.11.009_b0225","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.149.10.3339","article-title":"Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis","volume":"149","author":"Koziel","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0230","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1128\/JVI.67.12.7522-7532.1993","article-title":"Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV","volume":"67","author":"Koziel","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0235","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI118287","article-title":"HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release","volume":"96","author":"Koziel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.11.009_b0240","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2013.10.022","article-title":"Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors","volume":"146","author":"Kroy","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0245","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.23515","article-title":"Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia","volume":"51","author":"Kuniholm","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0250","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross-genotype immunity to hepatitis C virus","volume":"78","author":"Lanford","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0255","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/JVI.76.12.6104-6113.2002","article-title":"Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities","volume":"76","author":"Lauer","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0260","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.11.009_b0270","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/eji.200425875","article-title":"HLA-B27: portraying immunodominant viral epitopes","volume":"35","author":"Lopez de Castro","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0275","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1371\/journal.pone.0000649","article-title":"Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection","volume":"2","author":"Lucas","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2014.11.009_b0280","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T-cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.20261","article-title":"Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source","volume":"40","author":"McKiernan","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0290","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.11.009_b0295","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0300","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0305","doi-asserted-by":"crossref","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.11.009_b0310","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/JVI.77.8.4781-4793.2003","article-title":"Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees","volume":"77","author":"Nascimbeni","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0315","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.21049","article-title":"Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution","volume":"43","author":"Neumann-Haefelin","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","author":"Park","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2014.11.009_b0330","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2012.06.005","article-title":"Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus","volume":"143","author":"Park","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0335","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/nm.3408","article-title":"Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection","volume":"19","author":"Park","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0340","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection","volume":"45","author":"Penna","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0360","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2014.11.009_b0365","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0370","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20050122","article-title":"Divergent and convergent evolution after a common-source outbreak of hepatitis C virus","volume":"201","author":"Ray","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0375","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0380","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.4049\/jimmunol.181.12.8215","article-title":"High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection","volume":"181","author":"Rutebemberwa","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0385","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.3248","article-title":"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies","volume":"19","author":"Scheel","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0390","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.162.11.6681","article-title":"Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors","volume":"162","author":"Scognamiglio","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0510","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.20100388","article-title":"Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence","volume":"209","author":"Schulze zur Wiesch","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0395","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI200420985","article-title":"Hepatitis C virus mutation affects proteasomal epitope processing","volume":"114","author":"Seifert","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.11.009_b0400","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1074-7613(00)80147-8","article-title":"Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses","volume":"11","author":"Selin","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2014.11.009_b0405","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.20669","article-title":"Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection","volume":"41","author":"Semmo","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0410","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2011.05.006","article-title":"Delayed induction, not impaired recruitment, of specific CD8(+) T cells causes the late onset of acute hepatitis C","volume":"141","author":"Shin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0415","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/JVI.03122-12","article-title":"The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection","volume":"87","author":"Shin","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0420","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0425","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0430","first-page":"1437","article-title":"Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection","volume":"38","author":"Sugimoto","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0435","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"issue":"261","key":"10.1016\/j.antiviral.2014.11.009_b0440","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0445","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0198-8859(98)00102-5","article-title":"Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein","volume":"60","author":"Tabatabai","year":"1999","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0450","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0455","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2014.11.009_b0460","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20042284","article-title":"Immune evasion versus recovery after acute hepatitis C virus infection from a shared source","volume":"201","author":"Tester","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0465","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2014.11.009_b0470","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.11.009_b0475","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"2000","author":"Timm","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0480","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.21702","article-title":"Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution","volume":"46","author":"Timm","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.11.009_b0485","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nm893","article-title":"Advantage of rare HLA supertype in HIV disease progression","volume":"9","author":"Trachtenberg","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.11.009_b0490","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1365-2893.2006.00747.x","article-title":"Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses","volume":"13","author":"Ulsenheimer","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2014.11.009_b0495","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.01177-06","article-title":"PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion","volume":"80","author":"Urbani","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.11.009_b0500","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/495289a","article-title":"Time called on chimp work","volume":"495","author":"Wadman","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.11.009_b0505","first-page":"227","article-title":"Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection","volume":"25","author":"Weiner","year":"1995","journal-title":"Princess Takamatsu Symp."},{"key":"10.1016\/j.antiviral.2014.11.009_b9000","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.antiviral.2014.11.009_b9025","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T08:51:57Z","timestamp":1690707117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":96,"alternative-id":["S0166354214003301"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.11.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell responses in hepatitis C virus infection: Historical overview and goals for future research","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}